Institutional

9 de August de 2017

Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes

Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.

In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com

Back

Last related news

17 de September de 2025

Brazilian life-saving technology goes global: Braile Biomédica establishes international partnership with Zydus MedTech

Brazilian company Braile Biomédica, a leader in cardiovascular innovation, has announced an exclusive agreement with Indian firm Zydus MedTech to bring its … Brazilian life-saving technology goes global: Braile Biomédica establishes international partnership with Zydus MedTech

Felipe de Araújo Monteiro

8 de September de 2025

Kasznar Leonardos takes part in enforcement operation during the NFL game

Kasznar Leonardos’ Brand Protection & Anti-Piracy team was proud to coordinate and implement enforcement measures to curb the illegal trade of unauthorized … Kasznar Leonardos takes part in enforcement operation during the NFL game

Kasznar Leonardos

5 de September de 2025

Priscila Kashiwabara is recognized as Practitioner of the Year by LMG Life Sciences Americas Awards 2025

We are proud to announce that our partner Priscila Kashiwabara was recognized as Practitioner of the Year (Brazil) by the LMG Life … Priscila Kashiwabara is recognized as Practitioner of the Year by LMG Life Sciences Americas Awards 2025

Kasznar Leonardos